Epstein Files Search

EFTASearch

Search Entities About Settings

/to search

Dataset

Sort

Status

DOJ Status

Date Range

–

Page Count

–

Corpus: 1990-03-17 – 2025-12-01

March 2016

None

Light

Medium

Heavy

Results by Dataset3 total

Set 9

Set 11

3 results for “"Angiocrine Bioscience Inc"”

EFTA00327843Set 9

2016-03-153p700w

Keyboard Shortcuts

/

Focus search

Esc

Blur input

O

Open PDF

←→

Paginate

your feedback. Best regards, Paul Paul W. Finnegan, MD, MBA Chief Executive Officer

Angiocrine

Bioscience

Inc

. 3570 Cannel Mountain Rd. Suite 200, San Diego, CA 92130 From: Paul Finnegan Sent ... questions. Best regards, Paul Paul W. Finnegan, MD, MBA Chief Executive Officer

Angiocrine

Bioscience

Inc

. 3570 Carmel Mountain Rd, Suite 200, San Diego, CA 92130 Angioaine

Bioscience

Research Weill Cornell

https://www.justice.gov/epstein/files/DataSet%209/EFTA00327843.pdf

EFTA02397672Set 11

2p328w

Summary v150901.pdt Angiocrine Comp Analysis Trout Capital LLC-Angiocrine_v150818 0634 PFCGD FINAL.xlsx; Angiocrine Bioscience Inc 3.25 year Forecast_$5M+$25M v150902 0625.xlsx Dear Jeffrey, Attached are the 3 deliverables

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02397672.pdf

EFTA00292514Set 9

2017-04-276p1,776w

MEMORANDUM OF TERMS FOR PRIVATE PLACEMENT OF SERIES A-1 PREFERRED STOCK OF ANGIOCRINE BIOSCIENCE, INC. April 27, 2017 This memorandum summarizes the principal terms of the Series ... Preferred Stock financing of Angiocrine Bioscience, Inc. (the "Company"). The completion of the transactions contemplated by this memorandum will be subject to, among other things, satisfactory completion of financial

https://www.justice.gov/epstein/files/DataSet%209/EFTA00292514.pdf

Results by Dataset3 total

Set 9

Set 11

Corpus: 1990-03-17 – 2025-12-01

March 2016

None

Light

Medium

Heavy